UBS Asset Management Americas Inc. lowered its position in HCA Healthcare Inc (NYSE:HCA) by 3.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,172,967 shares of the company’s stock after selling 46,299 shares during the period. UBS Asset Management Americas Inc. owned 0.34% of HCA Healthcare worth $103,033,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in the business. Advisor Partners LLC boosted its holdings in HCA Healthcare by 13.5% in the fourth quarter. Advisor Partners LLC now owns 4,442 shares of the company’s stock worth $413,000 after acquiring an additional 528 shares in the last quarter. Ladenburg Thalmann Financial Services Inc. boosted its holdings in HCA Healthcare by 8.3% in the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 9,502 shares of the company’s stock worth $756,000 after acquiring an additional 729 shares in the last quarter. Amalgamated Bank boosted its holdings in HCA Healthcare by 2.3% in the third quarter. Amalgamated Bank now owns 33,983 shares of the company’s stock worth $2,705,000 after acquiring an additional 754 shares in the last quarter. Mutual of America Capital Management LLC lifted its holdings in shares of HCA Healthcare by 2.2% in the third quarter. Mutual of America Capital Management LLC now owns 35,732 shares of the company’s stock valued at $2,844,000 after purchasing an additional 761 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. lifted its holdings in shares of HCA Healthcare by 22.2% in the third quarter. Fuller & Thaler Asset Management Inc. now owns 4,400 shares of the company’s stock valued at $350,000 after purchasing an additional 800 shares in the last quarter. Institutional investors and hedge funds own 74.14% of the company’s stock.
Shares of HCA Healthcare Inc (HCA) opened at $101.00 on Wednesday. The company has a market capitalization of $35,359.29, a price-to-earnings ratio of 17.00, a P/E/G ratio of 1.01 and a beta of 0.48. HCA Healthcare Inc has a fifty-two week low of $71.18 and a fifty-two week high of $106.84. The company has a current ratio of 1.62, a quick ratio of 1.36 and a debt-to-equity ratio of -6.58.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 30th. The company reported $2.12 EPS for the quarter, topping the Zacks’ consensus estimate of $1.87 by $0.25. The business had revenue of $11.56 billion for the quarter, compared to analyst estimates of $11.19 billion. HCA Healthcare had a negative return on equity of 49.49% and a net margin of 4.89%. HCA Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company posted $1.80 earnings per share. analysts anticipate that HCA Healthcare Inc will post 8.71 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Investors of record on Thursday, March 1st will be issued a dividend of $0.35 per share. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.40 dividend on an annualized basis and a yield of 1.39%.
In other HCA Healthcare news, insider Charles J. Hall sold 35,949 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $103.09, for a total value of $3,705,982.41. Following the completion of the sale, the insider now directly owns 111,237 shares of the company’s stock, valued at $11,467,422.33. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Bill B. Rutherford sold 48,462 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $102.42, for a total value of $4,963,478.04. Following the completion of the sale, the chief financial officer now directly owns 41,269 shares of the company’s stock, valued at $4,226,770.98. The disclosure for this sale can be found here. Insiders have sold 432,436 shares of company stock worth $43,341,457 over the last quarter. 2.90% of the stock is currently owned by corporate insiders.
A number of research analysts have recently weighed in on HCA shares. Cantor Fitzgerald restated a “buy” rating and issued a $90.00 target price on shares of HCA Healthcare in a report on Tuesday, October 31st. Piper Jaffray Companies restated a “buy” rating and issued a $82.00 target price on shares of HCA Healthcare in a report on Wednesday, November 1st. Mizuho dropped their target price on HCA Healthcare from $85.00 to $84.00 and set a “buy” rating on the stock in a report on Wednesday, November 1st. Jefferies Group dropped their target price on HCA Healthcare from $90.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, November 1st. Finally, Credit Suisse Group started coverage on HCA Healthcare in a report on Thursday, November 2nd. They issued an “outperform” rating and a $95.00 target price on the stock. Three analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $104.50.
HCA Healthcare Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.